Viver Incorporadora e Construtora SA
BOVESPA:VIVR3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Viver Incorporadora e Construtora SA
BOVESPA:VIVR3
|
BR |
|
Abivax SA
PAR:ABVX
|
FR |
|
E
|
Edil San Felice SpA Societa Benefit
MIL:ESF
|
IT |
|
GTS Internasional Tbk PT
IDX:GTSI
|
ID |
|
Z
|
Zhejiang Century Huatong Group Co Ltd
SZSE:002602
|
CN |
|
A
|
Actinium Pharmaceuticals Inc
AMEX:ATNM
|
US |
|
D
|
Dingzing Advanced Materials Inc
TWSE:6585
|
TW |
|
I
|
InDex Pharmaceuticals Holding AB
STO:FLERIE
|
SE |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VIVR3's stock price target?
Not Available
VIVR3 doesn't have any price targets made by Wall Street professionals.
What is Viver Incorporadora e Construtora SA's Revenue forecast?
Projected CAGR
26%
For the last 14 years the
compound annual growth rate for
Viver Incorporadora e Construtora SA's revenue is
-21%.
The projected
CAGR
for the next 13 years is
26%.